KOTA KINABALU, Malaysia (Jan 6, 2025) – The European Wellness Biomedical Group (EWBG) and the Sytenko Institute of Spine and Joint Pathology (SISJP) in Kharkiv, Ukraine, have signed a Memorandum of Understanding (MOU) to collaborate on advanced research in regenerative medicine.
The partnership aims to accelerate scientific progress in the regeneration of bone, cartilage, and muscle tissue, particularly focusing on spinal cord injuries, fractures, and osteoarthritis. The MOU, signed during a virtual ceremo¬ny with participants in both Malaysia and Ukraine, marks a significant step toward addressing aging-related musculoskeletal conditions.
This strategic alliance brings together two prestigious institutions, with EWBG’s expertise spanning biotech research, bio-manufacturing, healthcare centers, and product distribution, and SISJP’s 117 years of clinical and scientific experience in orthopedics, traumatology, and age-related musculoskeletal diseases.
Professor Dr. Mike Chan, representing EWBG, and Dr. Stanislav Bondarenko, Director of SISJP, signed the MOU on January 6, 2025, in Kota Kinabalu, Malaysia, marking a significant milestone in the development of regenerative therapies aimed at enhancing the quality of life for patients worldwide.
In a heartfelt statement following the signing, Prof. Mike Chan shared,
This is a remarkable collaboration between Malaysia and top Ukrainian universities and experts in medicine and science. Together, we aim to advance research in stem cell therapy for spinal cord injuries, fractures, and osteoarthritis. With the expertise of leading Ukrainian professors and doctors working alongside us, I am confident we can achieve great breakthroughs. It’s the perfect time to move forward, leveraging the best talent from Ukraine and other parts of the world.
The partnership between EWBG and SISJP represents a unique collaboration, focusing particularly on the aging of the spine, which Prof. Chan highlighted: “The spine starts to age at 11. We aim to increase both the lifespan and the quality healthspan of the spine, as well as other organs along the way.”
As the collaboration expands, Prof. Chan emphasized the importance of leveraging global expertise:
We have collaborated with universities’ professors and research institutions worldwide, including the University of California, University of Heidelberg, and universities in Malaysia, Japan, and China. But stem cell research has deep roots in Ukraine, and it’s time to bring the best of Ukraine to the world stage.
He further elaborated on the specifics of this new partnership:
This collaboration is particularly exciting because we are focusing on spinal cord injuries and osteoarthritis. conditions that are closely linked to aging. The spine is one of the earliest organs to age, and this collaboration will help us address these challenges head-on.
Prof. Chan expressed optimism about the future outcomes of this joint research: “I am confident that this partnership will significantly advance the fields of bioengineering and medicine. We are committed to groundbreaking work in regenerative therapies for spinal injuries and osteoarthritis, with the potential to reverse and repair these conditions.”
The MOU also lays the groundwork for joint ventures in research and development, with both institutions committed to sharing their expertise in regenerative health through the European Wellness Academy and other professional platforms.
For more information about the European Wellness Biomedical Group and Sytenko Institute’s collaboration, please visit www.european-wellness.com.
Contact:
European Wellness Biomedical Group
Unit 67 & 68, Block K, Alamesra Plaza Utama, Jalan Sulaman
88450 Kota Kinabalu, Sabah, Malaysia
Phone: +60 88 123 4567
Email: [email protected]
Sytenko Institute of Spine and Joint Pathology
80, Hryhoriia Skovorody Street
Kharkiv, Ukraine, 61029
Phone: +38 057 123 4567
Email: [email protected]
Follow European Wellness on:
Follow European Wellness Academy on:
Follow Prof. Dato’ Sri Dr. Mike Chan on:
Comments are closed.